VIVUS, Inc. (VVUS): This Obesity Bet Just Became More Attractive
The importance of an FDA drug approval cannot be denied, but it is also a fact that the event can have different effects on the stock price.
February 12th, 2013 - News
February 5th, 2013 - News
February 1st, 2013 - News
January 22nd, 2013 - News
Returns since its inception in May 2014 (through November 14th, 2024)